Strophioblachia fimbricalyx
Strophioblachia fimbricalyx · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Strophioblachia fimbricalyx is a botanical species recognized for its significant biological potential in pharmacological research. Scientific investigations have highlighted its notable antiplasmodial and cytotoxic activities, suggesting value in combating malaria and cancer. The medicinal properties of this plant are primarily derived from its roots and leaves. Researchers often utilize preparations made from the whole plant or its specific aerial parts to study these effects. Consequently, this species remains a subject of interest for developing new therapeutic agents.
- Synonyms
- Blachia Glandulosa · Strophioblachia Glandulosa Var. Cordifolia · 4 more
- Common names
- Not available
- Family
- Euphorbiaceae
- Distribution
- Not available
- Plant Parts
- Root · Leaf
Classification
Synonyms
Strophioblachia fimbricalyx is a plant species characterized by a complex web of botanical synonyms that can sometimes confuse researchers. One notable synonym is Blachia glandulosa, which reflects different historical classifications of the same organism. The plant's taxonomic history also includes various forms, such as Strophioblachia fimbricalyx var. cordifolia and Strophioblachia fimbricalyx var. efimbriata. Further overlapping nomenclature can be found in names like Strophioblachia glandulosa and its specific variation, Strophioblachia glandulosa var. cordifolia. Understanding these relationships is essential for maintaining clarity within botanical studies and scientific documentation.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Strophioblachia fimbricalyx is a unique botanical specimen belonging to the vast kingdom Plantae. Within this biological realm, the plant is classified under the class Equisetopsida. It specifically falls under the order Malpighiales, showcasing its complex evolutionary lineage. Further narrowing its identity, it is a member of the genus Strophioblachia. Finally, this species is recognized as a distinct part of the Euphorbiaceae family.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Malpighiales |
| Family | Euphorbiaceae |
| Genus | Strophioblachia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Strophioblachia fimbricalyx exhibits a diverse geographical range that spans across various Asian climates. In temperate regions, this species is widely distributed throughout China, specifically within the South-Central and Southeast territories as well as the island of Hainan. Its presence also extends into tropical zones, where it thrives within the Indo-China peninsula. Specifically, documented populations can be found growing in the lush landscapes of Cambodia and Thailand. This broad distribution highlights the plant's ability to adapt to both temperate and tropical environments across the continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Strophioblachia fimbricalyx is a self-supporting plant that primarily exhibits a shrub-like growth form. This species demonstrates significant versatility in size, with individual specimens reaching a minimum height of only 0.5 meters. However, many plants in this category grow much larger, frequently surpassing a height of 2.375 meters. For those reaching their full potential, the maximum height can extend up to 4 meters. Such diverse dimensions allow this shrub to adapt effectively to its specific environmental niche.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Strophioblachia fimbricalyx serves as a significant source of bioactive secondary metabolites, particularly within its root system. Research has successfully isolated several specialized compounds from this plant, including phenanthrenones and phenanthropolones. These chemical constituents have demonstrated potent cytotoxic properties, showing effectiveness against various cancer cell lines such as NCI-H187 and KB. Furthermore, the plant's derivatives exhibit notable antiplasmodial activity against the Plasmodium falciparum parasite. Such diverse biological activities highlight the medicinal potential of this species in pharmacological development.
Compounds
Strophioblachia fimbricalyx is a plant species that has become a subject of scientific interest due to its potential chemical properties. Within this botanical context, research has focused on the isolation of specific bioactive compounds, such as compound 8. This particular diterpenoid has demonstrated significant anti-hypertrophic activity during rigorous biological testing. Molecular docking studies suggest that its effectiveness stems from its ability to lock the MAPK14 protein into an inactive conformation. Ultimately, these findings offer a promising natural scaffold for the development of future therapeutic agents.
Conditions
Strophioblachia fimbricalyx contains bioactive compounds that exhibit potential inhibitory activity against anticardiac hypertrophy. Specifically, certain constituents derived from the plant have demonstrated the ability to treat KB and NCI-H187 cancer cell lines through cytotoxic action. The plant also shows efficacy in treating MCF7 cancer cells, with specific compounds displaying measurable IC50 values. Furthermore, research into related species indicates that diterpenoids from this genus can inhibit NLRP3 inflammasome activation. Together, these findings highlight the diverse therapeutic potential of the plant against various pathological conditions.
Preparations
Strophioblachia fimbricalyx is prepared as aerial parts for the purification of several structurally intriguing diterpenoids, including strophioblachins A-K. These specific compounds, such as the rearranged diterpenoids 1-3 and the various other derivatives 4-11, were isolated from the aerial portions of the plant. Research into these aerial extracts revealed that certain components like compounds 10 and 15 possess potential anticardiac hypertrophic inhibitory activity. While the provided abstracts also detail the preparation of Strophioblachia glandulosa as a whole plant, the specific focus on Strophioblachia fimbricalyx relates to its aerial parts. Consequently, the chemical characterization and biological testing of this species are grounded in the use of these aerial plant components.
Parts used
Strophioblachia fimbricalyx is a botanical species that possesses distinct anatomical components such as roots and leaves. Research into its chemical composition has focused heavily on the bioactive compounds found within its root systems. Scientists have successfully isolated several phenanthrenone and phenanthropolone derivatives from these roots, demonstrating significant cytotoxic and antiplasmodial properties. While the leaves are also recognized as a part of the plant's structure, current studies emphasize the medicinal potential of its subterranean elements. Understanding these specific plant relationships is essential for advancing the development of new therapeutic agents.